How Will the Afluria Quadrivalent Market Grow? Key Trends and Opportunities for 2025 and Beyond
Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the afluria quadrivalent market grown in recent years?
In the past few years, the market size of Afluria Quadrivalent has exhibited an XX (HCAGR). This market is predicted to experience growth, escalating from $XX million in 2024 to $XX million in 2025, at a compound annual growth rate (CAGR) of XX%. Factors contributing to the growth during the historic period include increasing instances of chronic and infectious ailments, growing public understanding of vaccination benefits, rising elderly population, heightened vaccination rates facilitated by the government, and a climbing consumer inclination for vaccines.
How is the afluria quadrivalent market size expected to evolve during the forecast period?
Predictions show that the afluria quadrivalent market’s value is set to experience XX (FCAGR) growth over the upcoming years, potentially reaching $XX million by 2029 with an estimated compound annual growth rate (CAGR) of XX%. This expansion in the predicted period is linked to government-driven campaigns advocating for vaccinations, progress in vaccine technology, manufacturers’ escalated investments to modernize traditional vaccination production, medical professionals’ heightened preference for quadrivalent vaccines, and the application of numerous schemes and strategies to boost vaccine uptake. Key trends for the forecast period comprise the creation of innovative solutions, cutting-edge technology offering improved defense against viral mutations, pioneering vaccine technologies like adjuvanted or quadrivalent vaccines, and ongoing exploratory efforts in the vaccine technology sector.
Get your afluria quadrivalent market report here!
https://www.thebusinessresearchcompany.com/report/afluria-quadrivalent-global-market-report
Which key drivers are propelling the afluria quadrivalent market’s growth?
There is an expected upswing in the afluria quadrivalent market, attributable to the rising incidences of influenza. Influenza, an infectious respiratory ailment caused by the influenza virus, can cause mild to severe symptoms, such as fever, cough, and body aches. Some of the reasons behind this increasing prevalence include the virus’s yearly mutation, the seasonal environmental conditions, and insufficient vaccination protection in some communities. Afluria Quadrivalent is essential in countering this surge by offering protection against the four prominent flu strains, consequently decreasing infection risk and lessening the effects of seasonal epidemics. The UK Health Security Agency, as of November 2024, highlighted an uptick in influenza positivity rates in week 46, with an average weekly positivity rate of 3.9%, a climb from the preceding week’s 3.3%. The rates were highest in the 5 to 14 age group, having gone up to 11.6% from 8.8% in the earlier week. Therefore, the afluria quadrivalent market’s growth will be spurred on by the rising prevalence of influenza. An increase in birth rates will also likely cause the afluria quadrivalent market to grow. This rise in birth rates arises from factors like enhanced healthcare, government incentives, and evolving societal perspectives. More births lead to a greater pediatric population needing immunization. As more babies are born, healthcare systems will need to vaccinate more of them to guard against influenza, thus raising the demand for vaccines such as Afluria Quadrivalent. In October 2024, as per the Australian Bureau of Statistics, there were 24,737 Indigenous Australian births registered in 2023, a rise from the previous year by 349 infants. Consequently, the afluria quadrivalent market is set to grow due to rising birth rates.
What are the market segments in the afluria quadrivalent industry?
The afluria quadrivalentmarket covered in this report is segmented –
1) By Clinical Indication: Seasonal Influenza Prophylaxis; High-Risk Population Immunization; Pediatric Influenza Prophylaxis; Healthcare Worker Immunization
2) By Route Of Administration: Injection; Nasal Spray
3) By Age Group: Adults; Geriatric; Pediatrics
4) By Distribution Channel: Hospital And Retail Pharmacies; Government Suppliers; Other Channels
5) By End-User: Hospitals; Public; Private; Clinics; Other End-Users
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19862&type=smp
Which leading companies are shaping the growth of the afluria quadrivalent market?
Major companies operating in the afluria quadrivalent market include Seqirus Inc.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19862
Which geographic areas are influencing the growth of the afluria quadrivalent market?
North America was the largest region in the afluria quadrivalent market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the afluria quadrivalent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Inhalation Anesthesia Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/inhalation-anesthesia-global-market-report
Influenza A Virus Vaccine Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/h1n1-vaccine-global-market-report
Typhoid Vi Polysaccharide Vaccine Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
